Samsung Life Insurance Co Ltd
Samsung Life Insurance Co Ltd operates as a multiline insurance provider within the Financials sector, generating revenue through insurance premiums and investment income.
Business. Samsung Life Insurance Co Ltd (032830.KS) is a South Korean insurance company headquartered in Seoul that operates within the Financials sector. The firm engages in multiline insurance and brokerage activities, providing various insurance products to its customers. It is primarily listed on the Korea Exchange (KRX) under the ticker symbol 032830.KS. Specific details regarding operating segments or geographic revenue breakdowns are not available.
Analyst recommendations
20 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
1Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Samsung Life Insurance Co Ltd (032830.KS) has experienced no material changes in its fundamental profile or market signals during the recent analysis period. A comprehensive review of 17 key fields, excluding four schema-expansion fields, confirmed that the company’s status remains consistent with prior assessments, indicating a period of stability without significant operational or financial shifts. This lack of material change is further corroborated by the absence of any active watcher signals or cross-source alerts. The monitoring systems detected no new events, ratings adjustments, or holder movements that would typically trigger a reassessment of the insurer’s outlook, suggesting that the current market narrative around the stock remains unchanged. From a structural perspective, the company continues to be covered by five analysts, though it currently holds no index memberships and has no reported top holders or officer counts in the available data. This baseline configuration provides a static backdrop against which the absence of new developments is measured, reinforcing the conclusion that no new catalysts have emerged to alter the investment thesis. The significance of this stability lies in the predictability it offers to investors, as the absence of volatility in key metrics allows for a continued reliance on existing financial estimates and ESG profiles. Without new material changes to disrupt the status quo, the focus for stakeholders remains on the established fundamentals rather than reacting to emerging risks or opportunities.
Signals & dispatch
Composite-score breakdown
Synthesis
Samsung Life Insurance Co Ltd (032830.KS) is a South Korean insurance company headquartered in Seoul that operates within the Financials sector. The firm engages in multiline insurance and brokerage activities, providing various insurance products to its customers. It is primarily listed on the Korea Exchange (KRX) under the ticker symbol 032830.KS. Specific details regarding operating segments or geographic revenue breakdowns are not available.
Samsung Life Insurance maintains a capital structure characterized by a debt-to-equity ratio of 0.37, indicating moderate leverage relative to its equity base of 62.7 trillion KRW. The firm holds 4.5 trillion KRW in cash and equivalents against 23.5 trillion KRW in long-term debt, resulting in a negative net cash position as flagged in the risk assessment. Liquidity is assessed as medium, supported by an operating cash flow of 5.3 trillion KRW and a free cash flow of 1.7 trillion KRW. The balance sheet reflects total assets of 350.7 trillion KRW and total liabilities of 288.0 trillion KRW, consistent with the asset-heavy nature of the insurance business.
Profitability metrics show a return on equity (ROE) of 3.67% and a return on assets (ROA) of 0.66%, which are typical for large-scale insurers but suggest modest capital efficiency. The company reported net income of 2.3 trillion KRW on an operating income of 1.8 trillion KRW, indicating that non-operating items or tax effects contributed to the bottom line. Valuation multiples include a price-to-earnings ratio of 26.55 and a price-to-book ratio of 0.97, suggesting the market values the company near its book value while applying a premium for earnings stability. The EV/EBITDA ratio stands at 44.55, reflecting the capital-intensive and liability-driven nature of the business model.
Segment and geographic revenue mix data is not provided in the available input, preventing a detailed analysis of revenue concentration or regional exposure. The company operates as a multiline insurer, implying diversification across life, health, and accident products, but specific contribution margins by segment are absent from the current dataset.
Growth trajectory analysis is limited due to the absence of historical period data in the input. Without five-year annual or eight-quarter quarterly revenue and net income trends, it is not possible to assess the momentum of premium growth or earnings expansion. The current financial snapshot provides a static view of performance but lacks the temporal depth required for trend reasoning.
Risk factors include a medium liquidity rating and a low dilution risk, with no recent share issuance indicated as basic and diluted shares outstanding are identical at 179.6 million. The key flag notes that net cash is negative after subtracting total debt, which may constrain financial flexibility during periods of market stress. The absence of significant dilution sources suggests that equity capital is currently stable, though the negative net cash position warrants monitoring of debt maturity profiles.
Recent events are reflected in analyst estimates, with a mean price target of 360,214 KRW and a median target of 360,000 KRW, implying modest upside from the current market price of 340,500 KRW. The mean recommendation is 2.00, with five strong buys, ten buys, and five holds, indicating a generally positive sentiment among analysts. No specific filing, news, or transcript observations are provided in the input to detail recent corporate actions or strategic shifts.
Samsung Life Insurance Co Ltd (032830.KS) has experienced no material changes in its fundamental profile or market signals during the recent analysis period. A comprehensive review of 17 key fields, excluding four schema-expansion fields, confirmed that the company’s status remains consistent with prior assessments, indicating a period of stability without significant operational or financial shifts. This lack of material change is further corroborated by the absence of any active watcher signals or cross-source alerts. The monitoring systems detected no new events, ratings adjustments, or holder movements that would typically trigger a reassessment of the insurer’s outlook, suggesting that the current market narrative around the stock remains unchanged. From a structural perspective, the company continues to be covered by five analysts, though it currently holds no index memberships and has no reported top holders or officer counts in the available data. This baseline configuration provides a static backdrop against which the absence of new developments is measured, reinforcing the conclusion that no new catalysts have emerged to alter the investment thesis. The significance of this stability lies in the predictability it offers to investors, as the absence of volatility in key metrics allows for a continued reliance on existing financial estimates and ESG profiles. Without new material changes to disrupt the status quo, the focus for stakeholders remains on the established fundamentals rather than reacting to emerging risks or opportunities.
- The company trades at a price-to-book ratio of 0.97, suggesting valuation near intrinsic book value.
- Net cash is negative due to long-term debt exceeding cash and equivalents, posing a medium liquidity risk.
- Analyst sentiment is positive with a mean recommendation of 2.00 and a consensus price target above current levels.
- Return on equity of 3.67% reflects modest capital efficiency typical of the insurance sector.
- Dilution risk is low with no difference between basic and diluted shares outstanding.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Operating income −510,1% YoY; Net income +89,5% YoY.
- ▍Operating income −510,1% YoY
- ▍Net income +89,5% YoY
- ▍Free cash flow +79,8% YoY
Operating income +68,0% YoY; Net income +187,0% YoY.
- ▍Operating income +68,0% YoY
- ▍Net income +187,0% YoY
- ▍Free cash flow +133,2% YoY
Operating income +199,3% YoY; Net income +9,3% YoY.
- ▍Operating income +199,3% YoY
- ▍Net income +9,3% YoY
- ▍Free cash flow +0,7% YoY
Operating income +76,0% YoY; Net income +47,7% YoY.
- ▍Operating income +76,0% YoY
- ▍Net income +47,7% YoY
- ▍Free cash flow +42,0% YoY
Operating income KRW 385.68B.
- ▍Operating income KRW 385.68B
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 15 526,50 |
| Revenue | —no estimate | —no estimate | 4,10T KRW |
| Operating income | —no estimate | —no estimate | 2,95T KRW |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Return On Equitynet_income / total_equity
- Market Capmarket_price * shares_outstanding_diluted
- Enterprise Valuemarket_cap - net_cash
- Return On Assetsnet_income / total_assets
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Samsung Life Insurance Co Ltd Market data — financials · 2026-07-13
- Samsung Life Insurance Co Ltd Market data — analyst estimates · 2026-07-13
- Samsung Life Insurance Co Ltd Market data — ESG · 2026-07-13
- Samsung Life Insurance Co Ltd — company reference export (2026-07-05) · 2026-07-13